Association of pulse pressure with fibrinolysis in patients with type 2 diabetes

Thrombosis Research

Volumn 121, Issue 1, 2007, Pages 95-102

  Wakabayashi, Ichiro ^a,b   Masuda, Hiroshi ^c  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c Nishinomiya Kaisei Hospital   (Japan)

Author keywords

Atherosclerosis; Diabetes mellitus; Fibrinolysis; Pulse pressure; Thrombosis

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBIN III; FIBRINOGEN; PLASMIN; SIALIC ACID; THROMBIN;

ADULT; AGED; ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; COMMON CAROTID ARTERY; COMPLEX FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FIBRINOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PULSE PRESSURE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE;

EID: 35649006022     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.02.014     Document Type: Article

References (34)

1. Madhavan S., Ooi W.L., Cohen H., and Alderman M.H. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 23 (1994) 395-401
2. Benetos A., Safar M., Rudnichi A., Smulyan H., Richard J.L., Ducimetière P., et al. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 30 (1997) 1410-1415
3. Franklin S.S., Khan S.A., Wong N.D., Larson M.G., and Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 100 (1999) 354-360
4. Safar M.E., and London G.M. Therapeutic studies and arterial stiffness in hypertension: recommendations of the European Society of Hypertension. The Clinical Committee of Arterial Structure and Function. Working Group on Vascular Structure and Function of the European Society of Hypertension. J Hypertens 18 (2000) 1527-1535
5. Tate R.B., Manfreda J., Krahn A.D., and Cuddy T.E. Tracking of blood pressure over a 40-year period in the University of Manitoba Follow-up Study, 1948-1988. Am J Epidemiol 142 (1995) 946-954
6. Franklin S.S., Gustin IV W., Wong N.D., Larson M.G., Weber M.A., Kannel W.B., et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 96 (1997) 308-315
7. Franklin S.S., Jacobs M.J., Wong N.D., L'Italien G.J., and Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 37 (2001) 869-874
8. Safar M.E., St Laurent S., Safavian A.L., Pannier B.M., and London G.M. Pulse pressure in sustained essential hypertension: a haemodynamic study. J Hypertens 5 (1987) 213-218
9. O'Rourke M., and Frohlich E.D. Pulse pressure: Is this a clinically useful risk factor?. Hypertension 34 (1999) 372-374
10. Meade T.W., North W.R.S., Chakrabarti R., Stirling Y., Haines A.P., Thompson S.G., et al. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1 8177 (1980) 1050-1054
11. Wilhelmsen L., Svärdsudd K., Korsan-Bengtsen K., Larsson B., Welin L., and Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 311 (1984) 501-505
12. Ernst E., and Resch K.L. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 118 (1993) 956-963
13. Kannel W.B. Overview of hemostatic factors involved in atherosclerotic cardiovascular disease. Lipids 40 (2005) 1215-1220
14. Nadar S., and Lip G.Y.H. The prothrombotic state in hypertension and the effects of antihypertensive treatment. Curr Pharm Des 9 (2003) 1715-1732
15. Lip G.Y.H. Hypertension and the prothrombotic state. J Hum Hypertens 14 (2000) 687-690
16. Carr M.E. Diabetes mellitus: a hypercoagulable state. J Diabetes Complications 15 (2001) 44-54
17. Rajala U., Päivänsalo M., Laakso M., Pelkonen O., Suramo I., and Keinänen-Kiukaanniemi S. Associations of blood pressure with carotid intima-media thickness in elderly Finns with diabetes mellitus or impaired glucose tolerance. J Hum Hypertens 17 (2003) 705-711
18. de Vries R., Dallinga-Thie G.M., Smit A.J., Wolffenbuttel B.H.R., van Tol A., and Dullaart R.P.F. Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus. Diabetologia 49 (2006) 398-404
19. Anonymous. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20 (1997) 1183-1197
20. Suzuki K., Mori M., Masuya N., Abe N., Takeuchi K., Arai C., et al. Epidemiological studies of arteriosclerosis (I): association of aortic pulse wave velocity with hypertension, arteriolar sclerotic changes in the retina, and ischemic ECG changes. J Jpn Atheroscler Soc 23 (1996) 715-720 [in Japanese]
21. Handa N., Matsumoto M., Maeda H., Hougaku H., Ogawa S., Fukunaga R., et al. Ultrasonic evaluation of early carotid atherosclerosis. Stroke 21 (1990) 1567-1572
22. Lee K.W., Blann A.D., and Lip G.Y.H. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: relationship to thrombogenesis and endothelial damage/dysfunction. Am J Hypertens 18 (2005) 104-115
23. Smith F.B., Lee A.J., Fowkes F.G.R., Price J.F., Rumley A., and Lowe G.D.O. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 17 (1997) 3321-3325
24. Thögersen A.M., Jansson J.H., Boman K., Nilsson T.K., Weinehall L., Huhtasaari F., et al. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation 98 (1998) 2241-2247
25. van Hinsbergh V.W.M., Kooistra T., Emeis J.J., and Koolwijk P. Regulation of plasminogen activator production by endothelial cells: role in fibrinolysis and local proteolysis. Int J Radiat Biol 60 (1991) 261-272
26. Steins M.B., Padró T., Li C.X., Mesters R.M., Ostermann H., Hammel D., et al. Overexpression of tissue-type plasminogen activator in atherosclerotic human coronary arteries. Atherosclerosis 145 (1999) 173-180
27. Redmond E.M., Cahill P.A., Hirsch M., Wang Y.N., Sitzmann J.V., and Okada S.S. Effect of pulse pressure on vascular smooth muscle cell migration: the role of urokinase and matrix metalloproteinase. Thromb Haemost 81 (1999) 293-300
28. Koenig W. Haemostatic risk factors for cardiovascular diseases. Eur Heart J 19 (1998) C39-C43 [Suppl C]
29. Aso Y., Matsumoto S., Fujiwara Y., Tayama K., Inukai T., and Takemura Y. Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1. Metabolism 51 (2002) 471-476
30. Benetos A., Waeber B., Izzo J., Mitchell G., Resnick L., Asmar R., et al. Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens 15 (2002) 1101-1108
31. Franklin S.S., Larson M.G., Khan S.A., Wong N.D., Leip E.P., Kannel W.B., et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 103 (2001) 1245-1249
32. Lindberg G., Eklund G.A., Gullberg B., and Råstam L. Serum sialic acid concentration and cardiovascular mortality. BMJ 302 (1991) 143-146
33. Wakabayashi I., and Masuda H. Association of acute-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus. Clin Chim Acta 365 (2006) 230-235
34. Wakabayashi I., and Masuda H. Relation of serum sialic acid to blood coagulation activity in type 2 diabetes. Blood Coagul Fibrinolysis 13 (2002) 691-696